Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.483,03
-0,09%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Brainstorm Cell Therapeutics Inc (BCLI) Brainstorm Cell Therapeutics Inc (BCLI) Notizie

Brainstorm Cell Therapeutics Inc

BCLI
2,02
-0,07 (-3,35%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/1/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202522:10EDGAR2Form 3/A - Initial statement of beneficial ownership of..
03/1/202523:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:35EDGAR2Form 8-K - Current report
14/11/202421:24EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202413:55EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
30/10/202413:41EDGAR2Form 8-K - Current report
02/10/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:05EDGAR2Form 8-K - Current report
01/10/202414:00EDGAR2Form 8-K - Current report
26/9/202422:30EDGAR2Form 8-K - Current report
24/9/202422:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
17/9/202421:32EDGAR2Form S-3 - Registration statement under Securities Act of..
16/9/202422:36EDGAR2Form 8-K - Current report
28/8/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
16/8/202413:00EDGAR2Form DEF 14A - Other definitive proxy statements
14/8/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202413:15EDGAR2Form 8-K - Current report
06/8/202422:59EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
05/8/202423:11EDGAR2Form PRE 14A - Other preliminary proxy statements
30/7/202422:05EDGAR2Form 8-K - Current report
24/7/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202414:30PRNCABCLI Update - Progress Supports Our 10x Plus Value Range..
19/7/202422:05EDGAR2Form 8-K - Current report
14/6/202418:01PRNUSBCLI: Initiation - Potential 10x Return on Successful Phase..
04/6/202412:05EDGAR2Form 8-K - Current report
03/6/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202413:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202412:30PRNUSBrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn®..
23/2/202412:00PRNUSBrainStorm Cell Therapeutics Submits Special Protocol..
13/2/202412:30PRNUSBrainStorm Cell Therapeutics to Present at European Life..
12/2/202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 2,0476 Min: 1,90 Max: 2,115
Chiusura: 2,09

La tua Cronologia

NASDAQ
BCLI
Brainstorm Cell Therapeu...
AMEX
IPO
Renaissance IPO
LSE
YL75
Hsbc Bk. 27
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network